Atezolizumab with bevacizumab and nonplatinum chemotherapy for recurrent ovarian cancer: final results from the placebo-controlled AGO-OVAR 2.29/ENGOT-ov34 phase III trial : gynecologic cancer - Harter, Philipp; Marmé, Frederik; Redondo, Andrés; Reuss, Alexander; Lindemann, Kristina; Kurzeder, Christian; Van Nieuwenhuysen, Els; Marth, Christian; Pietzner, Klaus; Ray-Coquard, Isabelle; Garcia-Duran, Carmen; Jonuskiene, Goda; et al. (Journal of clinical oncology, 2026)
Online veröffentlicht: 3. Dezember 2025